GSK plc (BCBA:GSK)

Verve Therapeutics Statistics

Total Valuation

GSK plc has a market cap or net worth of ARS 101.84 trillion. The enterprise value is 125.49 trillion.

Market Cap	101.84T
Enterprise Value	125.49T

Important Dates

The last earnings date was Monday, July 28, 2025.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	May 16, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.49%
Shares Change (QoQ)	-0.65%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.90B

Valuation Ratios

The trailing PE ratio is 18.22 and the forward PE ratio is 8.24.

PE Ratio	18.22
Forward PE	8.24
PS Ratio	1.97
PB Ratio	4.35
P/TBV Ratio	n/a
P/FCF Ratio	9.73
P/OCF Ratio	8.08
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.58, with an EV/FCF ratio of 11.99.

EV / Earnings	22.45
EV / Sales	2.23
EV / EBITDA	7.58
EV / EBIT	11.43
EV / FCF	11.99

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.21.

Current Ratio	0.87
Quick Ratio	0.56
Debt / Equity	1.21
Debt / EBITDA	1.86
Debt / FCF	2.71
Interest Coverage	9.94

Financial Efficiency

Return on equity (ROE) is 28.33% and return on invested capital (ROIC) is 12.36%.

Return on Equity (ROE)	28.33%
Return on Assets (ROA)	6.58%
Return on Invested Capital (ROIC)	12.36%
Return on Capital Employed (ROCE)	15.88%
Revenue Per Employee	752.50M
Profits Per Employee	81.43M
Employee Count	68,629
Asset Turnover	0.54
Inventory Turnover	1.50

Taxes

In the past 12 months, GSK plc has paid 1.04 trillion in taxes.

Income Tax	1.04T
Effective Tax Rate	13.80%

Stock Price Statistics

The stock price has decreased by -5.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.05%
50-Day Moving Average	11,880.00
200-Day Moving Average	11,095.48
Relative Strength Index (RSI)	64.30
Average Volume (20 Days)	3,573

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of ARS 51.64 trillion and earned 5.59 trillion in profits. Earnings per share was 1,348.99.

Revenue	51.64T
Gross Profit	37.02T
Operating Income	10.08T
Pretax Income	7.55T
Net Income	5.59T
EBITDA	14.85T
EBIT	10.08T
Earnings Per Share (EPS)	1,348.99

Balance Sheet

The company has 5.91 trillion in cash and 28.33 trillion in debt, giving a net cash position of -22,424.99 billion.

Cash & Cash Equivalents	5.91T
Total Debt	28.33T
Net Cash	-22,424.99B
Net Cash Per Share	n/a
Equity (Book Value)	23.44T
Book Value Per Share	5,967.16
Working Capital	-4,416.42B

Cash Flow

In the last 12 months, operating cash flow was 12.61 trillion and capital expenditures -2,143.72 billion, giving a free cash flow of 10.47 trillion.

Operating Cash Flow	12.61T
Capital Expenditures	-2,143.72B
Free Cash Flow	10.47T
FCF Per Share	n/a

Margins

Gross margin is 71.69%, with operating and profit margins of 19.52% and 10.82%.

Gross Margin	71.69%
Operating Margin	19.52%
Pretax Margin	14.61%
Profit Margin	10.82%
EBITDA Margin	28.76%
EBIT Margin	19.52%
FCF Margin	20.27%

Dividends & Yields

This stock pays an annual dividend of 370.37, which amounts to a dividend yield of 2.92%.

Dividend Per Share	370.37
Dividend Yield	2.92%
Dividend Growth (YoY)	76.41%
Years of Dividend Growth	3
Payout Ratio	72.80%
Buyback Yield	-0.49%
Shareholder Yield	2.44%
Earnings Yield	5.49%
FCF Yield	10.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 22, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 1.82 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.82
Piotroski F-Score	6